The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2018

Filed:

May. 09, 2012
Applicant:

Jochen Reiser, Hinsdale, IL (US);

Inventor:

Jochen Reiser, Hinsdale, IL (US);

Assignee:

University of Miami, Miami, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/34 (2006.01); A61M 1/36 (2006.01); G01N 33/68 (2006.01); A61K 35/16 (2015.01); C07K 14/705 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3486 (2014.02); A61K 35/16 (2013.01); A61K 38/177 (2013.01); A61M 1/3496 (2013.01); A61M 1/362 (2014.02); A61M 1/3672 (2013.01); A61M 1/3687 (2013.01); C07K 14/70596 (2013.01); G01N 33/6872 (2013.01); A61M 1/3679 (2013.01);
Abstract

Focal segmental glomerulosclerosis (FSGS) is a common cause of proteinuric kidney disease, which comprises both native and transplanted kidneys. Treatment was limited in the past due to the complicated pathogenesis of FSGS, including previously unidentified serum factors. Here, serum soluble urokinase receptor (suPAR) is reported to be elevated in FSGS patients but not in patients with other primary glomerular diseases. Higher pre-transplantation suPAR levels are associated with risk for FSGS recurrence in kidney grafts. Renal disease only develops when suPAR sufficiently activates podocyte β3 integrin. Thus, disease pathogenesis can be stopped or slowed by ex vivo removal of suPAR from a subject's circulation. Removal may be measured by comparing the level (e.g., amount or concentration) of suPAR before and after such treatment.


Find Patent Forward Citations

Loading…